Liquid biopsy testing is a rapidly developing clinical application that is largely driven by new and innovative technologies. Join us on November 14th for the Liquid Biopsy in Clinical Practice seminar, where Dr. Daan van den Broek, Paul van der Leest, Dr. Alexander Sartori, and Joel Lechner will discuss how liquid biopsy testing is breaking new ground in cancer management. Register early as space is limited.
09:00 Arrival of participants
09:30 “Liquid biopsies and STRECK, getting things done.” Daan van den Broek, Netherlands Cancer Institute
10:15 “Preanalytical considerations and cfDNA quality assessment using the novel LiquID IQ assay.” Paul van der Leest, University Medical Center Groningen
11:00 Coffee Break
11:15 “Ultra-sensitive detection of somatic mutations in Liquid Biopsy with the MassARRAY System.” Dr. Alexander Sartori, Agena Bioscience
11:45 “Streck RNA Complete BCT; enabling discovery in cell-free RNA and extra-cellular vesicle research.” Joel Lechner, Streck